Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
xeraya@xeraya.com
+603 2381 8700
Submit a Proposal
proposal@xeraya.com
Back

Industry Updates

Stay up-to-date with the latest industry news and articles.
A Look at Next-Gen Tech: Neurostimulation and Cognitive Technology
  • Xeraya Admin
  • Posted by Xeraya Admin
January 28, 2023
9 min read

A Look at Next-Gen Tech: Neurostimulation and Cognitive Technology

The Current State of COVID: What Will We Face in 2023?
  • Xeraya Admin
  • Posted by Xeraya Admin
January 13, 2023
13 min read

The Current State of COVID: What Will We Face in 2023?

An introduction to Corporate Venture Capital (CVCs)
  • Xeraya Admin
  • Posted by Xeraya Admin
December 28, 2022
10 min read

An introduction to Corporate Venture Capital (CVCs)

A Sign of the Times – How the Challenge of Food Security will Affect Us
  • Xeraya Admin
  • Posted by Xeraya Admin
December 16, 2022
10 min read

A Sign of the Times – How the Challenge of Food Security will Affect Us

Are we there yet? Why the endemic might be two years away.
  • Xeraya Admin
  • Posted by Xeraya Admin
December 1, 2022
6 min read

Are we there yet? Why the endemic might be two years away.

ESG: Just a Trend or Here to Stay?
  • Xeraya Admin
  • Posted by Xeraya Admin
November 14, 2022
10 min read

ESG: Just a Trend or Here to Stay?

2023 Predictions – What the World will Face
  • Xeraya Admin
  • Posted by Xeraya Admin
October 20, 2022
7 min read

2023 Predictions – What the World will Face

In a Post-COVID World – The Pandemic’s Aftereffects
  • Xeraya Admin
  • Posted by Xeraya Admin
September 30, 2022
7 min read

In a Post-COVID World – The Pandemic’s Aftereffects

The 5 Key Considerations the Life Sciences Industry are Taking into Account in 2022
  • Xeraya Admin
  • Posted by Xeraya Admin
September 14, 2022
5 min read

The 5 Key Considerations the Life Sciences Industry are Taking into Account in 2022

Let’s Talk About Techquity
  • Xeraya Admin
  • Posted by Xeraya Admin
September 1, 2022
6 min read

Let’s Talk About Techquity

The Advent of Greenwashing
  • Xeraya Admin
  • Posted by Xeraya Admin
August 20, 2022
8 min read

The Impending Recession and Its Impact on Startups

The Advent of Greenwashing
  • Xeraya Admin
  • Posted by Xeraya Admin
August 8, 2022
5 min read

The Advent of Greenwashing

Sustainable Investing – A Vital Part of our Future
  • Xeraya Admin
  • Posted by Xeraya Admin
July 21, 2022
8 min read

Sustainable Investing – A Vital Part of our Future

Economic Tremors – 5 Key Sectors Affected by the Russia-Ukraine War
  • Xeraya Admin
  • Posted by Xeraya Admin
June 24, 2022
9 min read

Economic Tremors – 5 Key Sectors Affected by the Russia-Ukraine War

Post-COVID 19 Effects on the Healthcare Industry
  • Xeraya Admin
  • Posted by Xeraya Admin
June 10, 2022
7 min read

Post-COVID 19 Effects on the Healthcare Industry

Using Artificial Intelligence to Understand, Diagnose & Predict Rare Diseases
  • Xeraya Admin
  • Posted by Xeraya Admin
May 24, 2022
10 min read

Using Artificial Intelligence to Understand, Diagnose & Predict Rare Diseases

Using Artificial Intelligence to Understand, Diagnose & Predict Rare Diseases
  • Xeraya Admin
  • Posted by Xeraya Admin
May 24, 2022
8 min read

New Frontiers: How Researchers are Using AI to Speed Up the Detection and Diagnosis of Cancers

Impact Investing in Healthcare
  • Xeraya Admin
  • Posted by Xeraya Admin
May 9, 2022
5 min read

Impact Investing in Healthcare

The Global Burden of Antimicrobial Resistance
  • Xeraya Admin
  • Posted by Xeraya Admin
April 20, 2022
8 min read

The Global Burden of Antimicrobial Resistance

Innovations in the Battle Against AMR: MIT Researchers Develop Engineered Bacteria to Protect “Good” Gut Microbes
  • Xeraya Admin
  • Posted by Xeraya Admin
April 20, 2022
5 min read

Innovations in the Battle Against AMR: MIT Researchers Develop Engineered Bacteria to Protect “Good” Gut Microbes

It’s Not Over Yet: Why Vaccine Suppliers Will Continue to Thrive in the Endemic Phase of COVID-19.
  • Xeraya Admin
  • Posted by Xeraya Admin
April 5, 2022
6 min read

It’s Not Over Yet: Why Vaccine Suppliers Will Continue to Thrive in the Endemic Phase of COVID-19.

Malaysia's private equity and venture capital funding up 26.75% to $3.52B in 2021
  • Xeraya Admin
  • Posted by Xeraya Admin
March 28, 2022
7 min read

Malaysia's private equity and venture capital funding up 26.75% to $3.52B in 2021

Recent Trends in Oncology
  • Xeraya Admin
  • Posted by Xeraya Admin
March 23, 2022
7 min read

Recent Trends in Oncology

Three Areas of Cancer Research That Medical Experts are Excited About
  • Xeraya Admin
  • Posted by Xeraya Admin
March 22, 2022
5 min read

Three Areas of Cancer Research That Medical Experts are Excited About